Dipenkumar Modi

28PUBLICATIONS
174CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursHaematologyCardiovascular medicine and haematology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Jul 14, 2026
Infection Burden in Mismatched Unrelated Donor Hematopoietic Cell Transplantation: Results from the ACCESS Trial.

|Apr 21, 2026
Mosunetuzumab plus polatuzumab vedotin for relapsed/refractory MCL after BTK inhibitor therapy: a phase 2 study.

|Feb 24, 2026
A phase 1 study of blinatumomab/lenalidomide in relapsed/refractory B-cell lymphoma: toxicity, efficacy, and correlative analysis.

Joseph M Tuscano, Tamer Othman, Paul Frankel

|Nov 10, 2025
A phase 1 study of blinatumomab/lenalidomide in relapsed/refractory B-cell lymphoma: toxicity, efficacy, and correlative analysis.

Joseph M Tuscano, Tamer Othman, Paul Frankel

|Oct 06, 2025
Matched unrelated vs haploidentical donor hematopoietic cell transplantation using posttransplant cyclophosphamide.

Dipenkumar Modi, Yosra M Aljawai, Todd E DeFor

|Jul 30, 2025
Real-world outcomes of infections following tisagenlecleucel in patients with B-cell ALL: a CIBMTR analysis.

Hemalatha G Rangarajan, Prakash Satwani, Megan M Herr

Pageof 5

Frequent Collaborators

7 joint publications

Mehdi Hamadani

6 joint publications

Taiga Nishihori

5 joint publications

Antonio Martin Jimenez Jimenez

5 joint publications

Monzr M Al Malki